Stephanie Cruz

Stephanie Cruz supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing mission-critical procurement activities that enable public health response, laboratory diagnostics, and biomedical research capabilities. She oversees the acquisition of complex scientific instruments, diagnostic technologies, and data-driven public health services critical to infectious disease surveillance and laboratory capacity building. Her work directly supports CDC’s operational readiness by ensuring timely access to high-integrity analytical tools and technical services essential for national health security. Cruz maintains strategic relationships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid. These partnerships reflect a focus on large-scale, high-complexity contracts for diagnostic platforms, laboratory automation, epidemiological data systems, and biomedical research support services. Her contracting approach emphasizes performance-based outcomes, technical compliance, and long-term operational sustainability, often involving multi-year task orders and delivery orders under blanket purchase agreements. Her procurement portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition, indicating a preference for technical excellence and mission alignment over socioeconomic set-asides. While small business participation is not formally prioritized through designated programs, her contracting decisions are driven by vendor capability, innovation, and proven track record in delivering mission-critical public health solutions. Cruz’s primary NAICS focus areas include Administration of Public Health Programs, Analytical Laboratory Instrument Manufacturing, and Testing Laboratories and Services, reflecting deep expertise in procuring molecular diagnostics, clinical testing infrastructure, and data analytics platforms. She routinely acquires next-generation sequencing systems, real-time pathogen detection tools, and integrated surveillance software, demonstrating specialized knowledge in laboratory informatics, biosafety compliance, and public health IT ecosystems.